Viewing Study NCT04163432


Ignite Creation Date: 2025-12-24 @ 9:30 PM
Ignite Modification Date: 2026-03-05 @ 6:57 PM
Study NCT ID: NCT04163432
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-05
First Post: 2019-11-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC
Sponsor: University of Utah
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module